(833) 317-6278 
AMSTERDAM — Treatment with ruxolitinib cream, 1.5%, achieved rapid and marked reductions in the clinical signs and symptoms of cutaneous lichen
Liam Davenport
Geo Focus
Coverage Attributes:
Beta
Cites Data:
82
%
Press Release:
7
%
Industry Specific:
2
%
Expert Commentary:
2
%
Government Announcement:
1
%
Themes Covered:
Not enough data
Pitching Insights
Liam Davenport's coverage focuses on healthcare, pharmaceuticals, and scientific research. He frequently cites data in his articles, indicating a preference for evidence-based reporting. For effective outreach to Liam, consider providing access to credible and relevant data or studies that support the topic being pitched.
Given the prevalence of expert commentary in his coverage, it is likely that he would be interested in pitches from professionals with direct expertise or experience related to gene therapy, vision loss, hereditary conditions, medical research methodologies and results. These experts could provide valuable insights into emerging treatments or findings within these fields.
While Liam does not have a specified geographic focus, his interest appears broad and international given the nature of healthcare and scientific topics covered.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Most recent topics
Not enough data
